Innovator Intl Developed Power Buffer ETF

Innovator Intl Developed Power Buffer ETF

INOV
Innovator Intl Developed Power Buffer ETFUS flagNew York Stock Exchange Arca
33.99
USD
-0.23
(-0.16%)
1.87EPS
18.28P/E
11.81MMarket Cap
Innovator Intl Developed Power Buffer ETF
INOV
(New York Stock Exchange Arca)

Recent

price

33.99

P/E

ratio

18.28

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
This fund allocates a substantial portion of its net assets, typically at least 80%, to FLexible EXchange® Options tied to the iShares MSCI EAFE ETF. FLEX Options are a type of exchange-traded contract, distinguished by their customizable terms. The investment approach is structured to deliver specific results linked to the underlying ETF’s share price performance across a predetermined outcome period. This strategy aims to provide a buffer against the initial 15% of losses while capping potential upside gains over that annual period. The fund operates as a non-diversified investment vehicle.

Company News

  • Inovalon's Real-World Data and Analytics Fuel Forbes' Inaugural Top Hospitals List & Ratings

  • Inovalon's Empower 2025 Showcases the Next Chapter in Data-Driven Healthcare

  • Inovalon's Data Solutions Group Wins BioTech Breakthrough Award for Best Analytics Solution Provider of the Year

  • Inovalon Celebrates Visionaries' Transformative Achievements in Healthcare With 2025 Impact Awards

  • Inovalon Unveils New Capabilities Across the Healthcare Continuum to Drive Smarter, More Connected Care and Operations

  • Inovalon Powers 70% of Medicare Advantage Enrollees in 4+ Star Plans, Continuing to Outperform National Averages in 2026 CMS Star Ratings

  • Inovalon Collaborates With DoseMe to Bring Precision Dosing Into Pharmacy Surveillance Workflows

  • Inovalon's Annual Empower Summit Set to Advance Data-Driven Healthcare

  • Inovalon Launches New Data and Analytics Offering on Snowflake AI Data Cloud for Healthcare & Life Sciences

  • Inovalon's Converged Quality Achieves 25th Consecutive NCQA HEDIS® Measure Certification

  • Inovalon RADV Audit Readiness Solution Earns Top Ranking From Black Book

  • Nominations Now Open For 2025 Inovalon Impact Awards Honoring Healthcare Excellence

  • Ed Chidsey Appointed President of Inovalon's Insights Business Unit

  • Karly Rowe Appointed as President of Inovalon's Provider Business Unit

  • Former Inovalon Exec, Michael Hasbany, Joins Healthmine

  • Inovalon Adds Safety Management to the PointClickCare Marketplace

  • Inovalon's Pharmacy Surveillance Software Achieves Best in KLAS For Eight Years in a Row

  • Inovalon Announces CEO Transition

  • Alterwood Advantage Selects Inovalon's Converged Solution Suite to Drive Superior Quality Measurement and Risk Adjustment Accuracy

  • Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards